PL EN


Preferences help
enabled [disable] Abstract
Number of results
2002 | 50 | 5 | 297-306
Article title

Immunotherapy of cancer through targeting of the p53 tumor antigen

Title variants
Languages of publication
EN
Abstracts
EN
The expression of the p53 tumor suppressor protein is frequently increased in a great variety of human cancers, making this antigen an attractive candidate for targeting therapeutic T cell immunity. However, potential complications as a result of immunological tolerance or auto-immune pathology must be taken into account when exploiting this ubiquitously expressed auto-antigen for immunotherapy of cancer.
Keywords
Publisher

Year
Volume
50
Issue
5
Pages
297-306
Physical description
Contributors
References
Document Type
REVIEW
Publication order reference
S. Zwaveling, Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Tumor Immunology Group, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-626373d2-835f-3a71-b9c5-13b242de7977
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.